Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia

Pediatric Nephrology

Volumn 29, Issue 10, 2014, Pages 1997-2003

  Hamideh, Dima ^a   Raj, Vimal ^a   Harrington, Thomas ^a   Li, Hua ^b   Margolles, Emilio ^b   Amole, Folasade ^b   Garcia Buitrago, Monica ^b   Ruiz, Phillip ^b   Zilleruelo, Gaston ^a   Alvarez, Ofelia ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Albuminuria; Biomarkers; Hemosiderin; Nephropathy; Proteinuria; Sickle cell anemia

Indexed keywords

BIOLOGICAL MARKER; HAVCR1 PROTEIN, HUMAN; MEMBRANE PROTEIN; NAG PROTEIN, HUMAN; TUMOR PROTEIN; VIRUS RECEPTOR;

ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; ALBUMINURIA; BLOOD; CHILD; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; HEMOLYSIS; HUMAN; MALE; MIDDLE AGED; SICKLE CELL ANEMIA; URINE; YOUNG ADULT;

ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; ALBUMINURIA; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEMOLYSIS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTORS, VIRUS; YOUNG ADULT;

EID: 84930251611     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-014-2821-8     Document Type: Article

References (48)

1. Bunn HF (1997) Pathogenesis and treatment of sickle cell disease. N Engl J Med 337:762–769
2. Kaul DK, Hebbel RP (2000) Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 106:411–420
3. Osarogiagbon UR, Choong S, Belcher JD, Vercellotti GM, Paller MS, Hebbel RP (2000) Reperfusion injury pathophysiology in sickle transgenic mice. Blood 96:314–320
4. Nath KA, Katusic ZS (2012) Vasculature and kidney complications in sickle cell disease. J Am Soc Nephrol 23:781–784
5. Scheinman JI (2009) Sickle cell disease and the kidney. Nat Clin Pract Nephrol 5:78–88
6. Powars DR, Elliot-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C (1991) Chronic renal failure in sickle cell disease: Risk factors, clinical course, and mortality. Ann Intern Med 115:614–620
7. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP (1994) Mortality in sickle cell disease. N Engl J Med 330:1639–1644
8. Becker AM (2011) Sickle cell nephropathy: Challenging the conventional wisdom. Pediatr Nephrol 26:2099–2109
9. Sharpe CC, Thein SL (2011) Sickle cell nephropathy – a practical approach. Br J Haematol 155:287–297
10. Alvarez O, Zilleruelo G, Wright D, Montane B, Lopez-Mitnik G (2006) Serum cystatin C levels in children with sickle cell disease. Pediatr Nephrol 21:533–537
11. Alvarez O, Montane B, Lopez G, Wilkinson J, Miller T (2006) Early blood transfusions protect against microalbuminuria in children with sickle cell disease. Pediatr Blood Cancer 47:71–76
12. Guasch A, Navarrete J, Nass K, Zayas CF (2006) Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol 17:2228–2235
13. Koyner JL, Vaidya VS, Bennett MR, Ma Q, Worcester E, Akhter SA, Raman J, Jeevanandam V, O'Connor MF, Devarajan P, Bonventre JV, Murray PT (2010) Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 5:2154–2165
14. Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, Troth S, Muniappa N, Thudium D, Gerhold D, Holder DJ, Bobadilla NA, Marrer E, Perentes E, Codier A, Vonderscher J, Maurer G, Goering PL, Sistare FD, Bonventre JV (2010) Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol 28:478–485
15. Bonventre JV, Vaidya VS, Schmouder R, Feig P, Dieterle F (2010) Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol 28:436–440
16. Hoffmann D, Adler M, Vaidya VS, Rached E, Mulrane L, Gallagher WM, Callanan JJ, Gautier JC, Matheis K, Staedtler F, Dieterle F, Brandenburg A, Sposny A, Hewitt P, Ellinger-Ziegelbauer H, Bonventre JV, Dekant W, Mally A (2010) Performance of novel kidney biomarkers in preclinical toxicity studies. Toxicol Sci 116:8–22
17. Devarajan P (2008) Emerging urinary biomarkers in the diagnosis of acute kidney injury. Expert Opin Med Diagn 2:387–398
18. Devarajan P (2010) Review: Neutrophil gelatinase-associated lipocalin: A troponin-like biomarker for human acute kidney injury. Nephrology 15:419–428
19. Sundaram N, Bennett M, Wilhelm J, Kim MO, Atweh G, Devarajan P, Malik P (2011) Biomarkers for early detection of sickle nephropathy. Am J Hematol 86:559–566
20. Voskaridou E, Terpos E, Michail S, Hantzi E, Anagnostopoulos A, Margeli A, Simirloglou D, Loukopoulos D, Papassotiriou I (2006) Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia. Kidney Int 69:2037–2042
21. Mohtat D, Thomas R, Du Z, Boakye Y, Moulton T, Driscoll C, Woroniecki R (2011) Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease. Pediatr Nephrol 26:275–280
22. Nauta FL, Boertien WE, Bakker SJ, van Goor H, van Oeveren W, de Jong PE, Bilo H, Gansevoort RT (2011) Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care 34:975–981
23. Devarajan P (2011) Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr 23:194–200
24. Tharaux PL, Hagège I, Placier S, Vayssairat M, Kanfer A, Girot R, Dussaule JC (2005) Urinary endothelin-1 as a marker of renal damage in sickle cell disease. Nephrol Dial Transplant 20:2408–2413
25. Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637
26. Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. J Am Soc Nephrol 4:1832–1843
27. Chronic Kidney Disease Epidemiology Collaboration, Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F (2006) Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254
28. Filler G, Foster J, Acker A, Lepage N, Akbari A, Ehrich JH (2005) The Cockcroft-Gault formula should not be used in children. Kidney Int 67:2321–2324
29. Chaturvedi S, Farmer T, Kapke GF (2009) Assay validation for KIM-1: human urinary renal dysfunction biomarker. Int J Biol Sci 5:128–134
30. Palmer LS, Maizels M, Kaplan WE, Firlit CF, Cheng EY (1997) Urine levels of transforming growth factor-beta 1 in children with uretero-pelvic junction obstruction. Urology 50:769–773
31. Henry JB (2001) Clinical diagnosis and management by laboratory methods, 20th edn. W.B. Saunders, Philadelphia
32. Zamboni P, Izzo M, Fogato L, Carandina S, Lanzara V (2003) Urine hemosiderin: a novel marker to assess the severity of chronic venous disease. J Vasc Surg 37:132–136
33. Ashley-Koch AE, Okocha EC, Garrett ME, Soldano K, De Castro LM, Jonassaint JC, Orringer EP, Eckman JR, Telen MJ (2011) MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol 155:386–394
34. Sklar AH, Campbell H, Caruana RJ, Lightfoot BO, Gaier JG, Milner P (1990) A population study of renal function in sickle cell anemia. Int J Artif Organs 13:231–236
35. Montgomery R, Zibari G, Hill G, Ratner LE (1994) Renal transplantation in patients with sickle cell nephropathy. Transplantation 58:618–620
36. Ataga KI, Orringer EP (2000) Renal abnormalities in sickle cell disease. Am J Hematol 63:205–211
37. Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40:221–226
38. Roos JF, Doust J, Tett SE, Kirkpatrick CM (2007) Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children: a meta-analysis. Clin Biochem 40:383–391
39. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, Rossert J, Van Lente F, Bruce RD 3rd, Zhang YL, Greene T, Levey AS (2008) Estimated GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis 51:395–406
40. Alvarez O, Lopez-Mitnik G, Zilleruelo G (2008) Short-term follow-up of patients with sickle cell disease and albuminuria. Pediatr Blood Cancer 50:1236–1239
41. Abbate M, Benigni A, Bertani T, Remuzzi G (1999) Nephrotoxicity of increased glomerular protein traffic. Nephrol Dial Transplant 14:304–312
42. Honkanen E, Teppo AM, Tornroth T, Groop PH, Grönhagen-Riska C (1997) Urinary transforming growth factor-βl in membranous glomerulonephritis. Nephrol Dial Transplant 12:2562–2568
43. Lüscher TF (1991) Endothelin. J Cardiovasc Pharmacol 18:S15–S22
44. Simonson MS, Ismail-Beigi F (2011) Endothelin-1 increases collagen accumulation in renal mesangial cells by stimulating a chemokine and cytokine autocrine signaling loop. J Biol Chem 286:11003–11008
45. Kato GJ, Gladwin MT, Steinberg MH (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 21:37–47
46. Becton LJ, Kalpatthi RV, Rackoff E, Disco D, Orak JK, Jackson SM, Shatat IF (2010) Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatr Nephrol 25:1505–1511
47. Gurkan S, Scarponi KJ, Hotchkiss H, Savage B, Drachtman R (2010) Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia. Pediatr Nephrol 25:2123–2127
48. Schein A, Enriquez C, Coates TD, Wood JC (2008) Magnetic resonance detection of kidney iron deposition in sickle cell disease: a marker of chronic hemolysis. J Magn Reson Imaging 28:698–704